Amy Legg
Impact in
-
- Antibiotic Use and Resistance
-
- Antibiotics Pharmacokinetics and Efficacy
- Drug-Induced Adverse Reactions
- Pharmacogenetics and Drug Metabolism
Papers in
- Pharmacology 11
- Antibiotics Pharmacokinetics and Efficacy 7
- Drug-Induced Adverse Reactions 3
-
- Antimicrobial Resistance in Staphylococcus 3
- Co-authors
- Michael Barras (1 shared paper)Kate McCarthy (4 shared papers)Jason A. Roberts (4 shared papers)Ming G. Chai (1 shared paper)Menino Osbert Cotta (1 shared paper)Krispin Hajkowicz (1 shared paper)Kevin O’Callaghan (1 shared paper)Joshua S. Davis (3 shared papers)
- Journals
- European Journal of Clinical Microbiology & Infectious Diseases (2 papers)Antibiotics (1 paper)Current Opinion in Critical Care (1 paper)Nephrology (1 paper)International Journal of Antimicrobial Agents (1 paper)
- Partner nations
- AustraliaFranceUnited States
In The Last Decade
Amy Legg
16 papers receiving 168 citations
Peers
Comparison fields: 5 of 62
- Applied Microbiology and Biotechnology 13
- Pharmacology 58
- Molecular Medicine 8
- Geriatrics and Gerontology 4
- Pharmacology 9
Countries citing papers authored by Amy Legg
This map shows the geographic impact of Amy Legg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Legg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Legg more than expected).
Fields of papers citing papers by Amy Legg
This network shows the impact of papers produced by Amy Legg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Legg. The network helps show where Amy Legg may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Legg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 85 | |
| 2 | 2023 | 20 | |
| 3 | 2019 | 19 | |
| 4 | 2022 | 8 | |
| 5 | 2020 | 7 | |
| 6 | 2024 | 6 | |
| 7 | 2020 | 6 | |
| 8 | 2023 | 4 | |
| 9 | 2025 | 4 | |
| 10 | 2023 | 3 | |
| 11 | 2025 | 3 | |
| 12 | 2023 | 2 | |
| 13 | 2021 | 1 | |
| 14 | 2025 | 1 | |
| 15 | 2025 | 1 | |
| 16 | 2019 | 1 | |
| 17 | 2026 | 0 | |
| 18 | 2024 | 0 |
About Amy Legg
Amy Legg is a scholar working on Pharmacology, Infectious Diseases, Epidemiology, Applied Microbiology and Biotechnology and Oncology, having authored 18 papers that have together received 171 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Antibiotic Use and Resistance (3 papers), Drug-Induced Adverse Reactions (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Pneumonia and Respiratory Infections (2 papers), Neutropenia and Cancer Infections (2 papers), Parasites and Host Interactions (1 paper) and Contact Dermatitis and Allergies (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (13 citations), Pharmacology (58 citations), Molecular Medicine (8 citations), Geriatrics and Gerontology (4 citations) and Pharmacology (9 citations). Amy Legg has collaborated with scholars based in Australia, France and United States. Frequent co-authors include Michael Barras, Kate McCarthy, Jason A. Roberts, Ming G. Chai, Menino Osbert Cotta, Krispin Hajkowicz, Kevin O’Callaghan, Joshua S. Davis, Niamh Meagher and Sandra Johnson. Their work appears in journals such as European Journal of Clinical Microbiology & Infectious Diseases, Antibiotics, Current Opinion in Critical Care, Nephrology and International Journal of Antimicrobial Agents.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.